SCHEMBL29694189

SCHEMBL29694189

CCN(CC)c1ccc2c(C)c(CCOC(=O)NCc3cncc(NC(C)=O)c3)c(=O)oc2c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IGLV6-57 P01721 13/20 1.00
▸ KDM4E B2RXH2 4/20 0.50
▸ ALDH1A1 P00352 4/20 0.50
▸ GLA P06280 3/20 0.50
▸ ATM Q13315 3/20 0.50
▸ HTT P42858 3/20 0.50
▸ CASP1 P29466 2/20 0.50
▸ CASP7 P55210 2/20 0.50
▸ HSD17B10 Q99714 2/20 0.50
▸ LMNA P02545 1/20 0.50
▸ MAPT P10636 1/20 0.50
▸ THRB P10828 1/20 0.50
▸ L3MBTL1 Q9Y468 1/20 0.50
▸ GAA P10253 2/20 0.48
▸ KLK7 P49862 1/20 0.48
▸ SRC P12931 2/20 0.44
▸ TDP1 Q9NUW8 1/20 0.43
▸ MEN1 O00255 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24590056 1.00 IGLV6-57 (1.00) IGLV6-57KDM4EALDH1A1GLAATM
SCHEMBL24590078 0.89 IGLV6-57 (1.00) IGLV6-57KDM4EALDH1A1GLAATM
SCHEMBL29694244 0.89 IGLV6-57 (1.00) IGLV6-57KDM4EALDH1A1GLAATM
SCHEMBL29694240 0.87 IGLV6-57 (0.77) IGLV6-57KDM4EALDH1A1GLAATM
SCHEMBL24589366 0.87 IGLV6-57 (0.77) IGLV6-57KDM4EALDH1A1GLAATM
SCHEMBL24589814 0.86 IGLV6-57 (1.00) IGLV6-57KDM4EALDH1A1GLAATM
SCHEMBL29694159 0.86 IGLV6-57 (1.00) IGLV6-57KDM4EALDH1A1GLAATM
SCHEMBL24589536 0.85 IGLV6-57 (0.84) IGLV6-57KDM4EALDH1A1GLAATM
SCHEMBL24590000 0.84 IGLV6-57 (1.00) IGLV6-57KDM4EALDH1A1GLAATM
SCHEMBL24589383 0.83 IGLV6-57 (0.77) IGLV6-57KDM4EALDH1A1GLAATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11945806-B2 Stabilization of amyloidogenic immunoglobulin light chains THE SCRIPPS RESEARCH INSTITUTE 2024-04-02 — — US disclosed
US-20220204485-A1 STABILIZATION OF AMYLOIDOGENIC IMMUNOGLOBULIN LIGHT CHAINS THE SCRIPPS RESEARCH INSTITUTE 2022-06-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220204485-A1 STABILIZATION OF AMYLOIDOGENIC IMMUNOGLOBULIN LIGHT CHAINS TTR, MAP1LC3B, SAAL1 IGLV6-57 7/4885KDM4E 4575/4885ALDH1A1 2072/4885
US-11945806-B2 Stabilization of amyloidogenic immunoglobulin light chains TTR, MAP1LC3B, SAAL1 IGLV6-57 7/4885KDM4E 4575/4885ALDH1A1 2072/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback